Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ELDER PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ELDER PHARMA ABBOTT INDIA/
ELDER PHARMA
 
P/E (TTM) x 50.0 -1.0 - View Chart
P/BV x 18.2 0.1 18,035.8% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 ABBOTT INDIA   ELDER PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
ELDER PHARMA
Jun-14
ABBOTT INDIA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs22,482380 5,916.3%   
Low Rs16,156188 8,593.6%   
Sales per share (Unadj.) Rs2,517.0489.2 514.5%  
Earnings per share (Unadj.) Rs446.8-3.2 -14,051.3%  
Cash flow per share (Unadj.) Rs479.714.4 3,329.3%  
Dividends per share (Unadj.) Rs325.000-  
Avg Dividend yield %1.70-  
Book value per share (Unadj.) Rs1,480.5376.5 393.2%  
Shares outstanding (eoy) m21.2520.54 103.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.70.6 1,322.2%   
Avg P/E ratio x43.2-89.3 -48.4%  
P/CF ratio (eoy) x40.319.7 204.3%  
Price / Book Value ratio x13.00.8 1,730.2%  
Dividend payout %72.70-   
Avg Mkt Cap Rs m410,5135,832 7,038.4%   
No. of employees `000NANA-   
Total wages/salary Rs m5,6362,179 258.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,48710,048 532.3%  
Other income Rs m1,543257 601.3%   
Total revenues Rs m55,03010,305 534.0%   
Gross profit Rs m12,0552,921 412.7%  
Depreciation Rs m700361 193.7%   
Interest Rs m1602,756 5.8%   
Profit before tax Rs m12,73860 21,283.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,244125 2,592.0%   
Profit after tax Rs m9,494-65 -14,537.0%  
Gross profit margin %22.529.1 77.5%  
Effective tax rate %25.5209.1 12.2%   
Net profit margin %17.8-0.6 -2,730.9%  
BALANCE SHEET DATA
Current assets Rs m30,2519,240 327.4%   
Current liabilities Rs m12,0609,998 120.6%   
Net working cap to sales %34.0-7.5 -451.0%  
Current ratio x2.50.9 271.4%  
Inventory Days Days87128 67.7%  
Debtors Days Days2602 0.4%  
Net fixed assets Rs m15,13513,642 110.9%   
Share capital Rs m213206 103.3%   
"Free" reserves Rs m31,2487,528 415.1%   
Net worth Rs m31,4607,733 406.8%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m45,38622,882 198.3%  
Interest coverage x80.71.0 7,894.9%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.20.4 268.4%   
Return on assets %21.311.8 180.9%  
Return on equity %30.2-0.8 -3,573.5%  
Return on capital %41.022.3 183.8%  
Exports to sales %0.43.1 13.6%   
Imports to sales %10.80.4 2,512.5%   
Exports (fob) Rs m221307 72.1%   
Imports (cif) Rs m5,76543 13,375.4%   
Fx inflow Rs m310307 101.0%   
Fx outflow Rs m5,818125 4,644.0%   
Net fx Rs m-5,508181 -3,037.6%   
CASH FLOW
From Operations Rs m8,93411,754 76.0%  
From Investments Rs m-1,477-561 263.5%  
From Financial Activity Rs m-6,387-6,762 94.5%  
Net Cashflow Rs m1,0705,466 19.6%  

Share Holding

Indian Promoters % 0.0 25.3 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.9 24.0 37.2%  
FIIs % 0.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 74.7 33.5%  
Shareholders   72,252 31,548 229.0%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs Elder Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs Elder Pharma Share Price Performance

Period Abbott India Elder Pharma S&P BSE HEALTHCARE
1-Day 0.74% 4.97% 1.18%
1-Month -5.97% 21.21% -0.75%
1-Year 24.80% -64.54% 61.82%
3-Year CAGR 21.40% -51.65% 18.16%
5-Year CAGR 29.91% -37.46% 19.79%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the Elder Pharma share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of Elder Pharma the stake stands at 25.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of Elder Pharma.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

Elder Pharma paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Abbott India, and the dividend history of Elder Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.